News

Japan-based Fujirebio's test, which helps doctors diagnose Alzheimer's disease, is intended for patients with signs of ...
The FDA cleared the first blood test on Friday to help diagnose Alzheimer's disease among older Americans already exhibiting ...
The new test, from Fujirebio Diagnostics, Inc., identifies a sticky brain plaque, known as beta-amyloid, that is a key marker ...
U.S. regulators have approved the first blood test to help diagnose Alzheimer’s disease, potentially making it easier to find ...
The FDA has cleared the Lumipulse G pTau217/β-Amyloid 1-42 Plasma Ratio test, the first blood test for early Alzheimer's ...
The Lumipulse Alzheimer's blood test is the first of a new generation of tests that may replace brain scans and spinal taps to detect the disease.
The FDA said the results of the newly cleared blood test must be assessed in conjunction with other clinical information from ...
The United States on Friday approved the first blood test for Alzheimer's, a move that could help patients begin treatment ...
US regulators have approved the first blood test to help diagnose Alzheimer’s disease, potentially making it easier to find ...
CHENNAI: In a milestone move, the US Food and Drug Administration has given the green light to the world's first blood test ...
The new test, known as the Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, detects amyloid plaques through blood testing, a ...